Why Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Stock Should Not Be Taken For Granted By Investors In 2025

IPW

In the last trading session, 2.24 million shares of the Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) were traded, and its beta was 0.93. Most recently the company’s share price was $13.08, and it changed around -$0.9 or -6.44% from the last close, which brings the market valuation of the company to $1.80B. ARWR currently trades at a discount to its 52-week high of $30.41, offering almost -132.49% off that amount. The share price’s 52-week low was $9.57, which indicates that the current value has risen by an impressive 26.83% since then.

Arrowhead Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.57. If we narrow it down even further, the data shows that 0 out of 15 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 5 recommended ARWR as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) trade information

Instantly ARWR has showed a red trend with a performance of -6.44% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 14.97 on recent trading dayincreased the stock’s daily price by 12.63%. The company’s shares are currently down -30.43% year-to-date, but still down -2.90% over the last five days. On the other hand, Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is 22.47% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $26.98, which translates to bulls needing to increase their stock price by 51.52% from its current value. Analyst projections state that ARWR is forecast to be at a low of $24 and a high of $29.97.

Arrowhead Pharmaceuticals Inc earnings are expected to increase by 41.08% in 2025, but the outlook is positive 11.11% per year for the next five years.

ARWR Dividends

Arrowhead Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.

VANGUARD GROUP INC, with 9.8343% or 12.21 million shares worth $317.44 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 7.85 shares worth $102.62 million, making up 5.71% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 3.66 shares worth around $47.91 million, which represents about 2.67% of the total shares outstanding.